MK-677 vs Ipamorelin: Oral vs Injectable GH Research
When designing growth hormone research protocols, MK-677 (Ibutamoren) and Ipamorelin represent two distinct approaches: oral vs injectable administration. Both stimulate growth hormone secretion but through different pathways and with very different practical considerations.
What Is MK-677?
MK-677 (Ibutamoren) is an orally active growth hormone secretagogue that mimics ghrelin. Unlike injectable peptides, MK-677 is taken by mouth and has a long half-life of approximately 24 hours, allowing once-daily dosing. It stimulates both growth hormone and IGF-1 release, making it popular in research protocols focused on muscle, bone density, and sleep quality.
What Is Ipamorelin?
Ipamorelin is an injectable pentapeptide growth hormone secretagogue with high selectivity for GH release. Its short half-life (~2 hours) means it is typically administered multiple times daily in research settings. Ipamorelin is valued for its minimal impact on cortisol and prolactin.
Key Comparison
| Factor | MK-677 | Ipamorelin |
|---|---|---|
| Administration | Oral (daily) | Injectable (2-3x daily) |
| Half-life | ~24 hours | ~2 hours |
| GH pulse | Sustained elevation | Sharp pulses |
| IGF-1 impact | Significant | Moderate |
| Appetite stimulation | Yes | Minimal |
Research Applications
MK-677 is often studied for long-term GH/IGF-1 elevation, bone density research, and sleep studies. Ipamorelin is preferred when researchers want precise GH pulse control or when avoiding appetite-stimulating effects is important. Some protocols even stack them, though this requires careful timing consideration.
For more on combining growth hormone peptides, read our complete GHRP and GHRH analog guide and peptide stacking guide.
Where to Buy
Hanpro Peptides offers both MK-677 and Ipamorelin with verified purity. Visit our shop for the complete catalog.
Conclusion
MK-677 offers convenience and sustained GH elevation via oral administration, while Ipamorelin provides precise, selective GH pulses through injection. The right choice depends on your research protocol objectives and administration preferences.
